Liquim. Ltd. announces the appointment of Grant Pestell to the Liquim Board.
“Having worked with Grant over many years in an informal capacity, having him join Liquim’s Board as Chair provides an opportunity to be working with him in a more formal capacity. I hope that together we can make great things happen“ – Sheryl Frame, Liquim’ s Chief Officer (CEO). Grant has over 25 years’ experience […]
Liquim Ltd announced restructure of management positions
In the two years and three months since Liquim’s inception, our biotechnology company has been making strong progress in its goal of providing solutions for a better world. This rapid growth has necessitated restructuring the organisation to ensure that we can take advantage of all opportunities. Effective today, I am pleased to announce that I […]
Ailene Thiel, International Collaboration and Commercialisation Expert joins the Liquim team
Liquim Pty. Ltd. announces the appointment of Ailene Thiel to our advisory team. “We are thrilled to have Ailene Thiel join our exciting journey, and look forward to working together on reducing risks to public health by bringing novel healthcare solutions to market” says Velimir Pajic, Liquim’s Chief Executive/Scientific Officer (CESO). Ailene Thiel is an […]
Sheryl Frame joins Liquim’s board
Liquim Pty. Ltd. Is pleased to announce that Sheryl Frame has been appointed as a Director to its Board. Sheryl continues to act in her role as the company’s Chief Business Development Officer (CBDO). “Sheryl has been a pivotal part in Liquim’s journey. We look forward to her continued contribution to the future success of […]
New Appointment
Liquim Pty Ltd announces the appointment of Dr Clay Golledge as Chief Medical Advisor. “We are happy to announce the appointment of Dr Golledge as a great addition to our Western Australian based medical biotechnology company”, says Sheryl Frame, Liquim’ s Chief Business Development Officer (CBDO). Clay is a well-known Physician in Infection Management and […]
